MSC Co., Ltd. (KOSDAQ:009780)

Market Cap	142.03B
Revenue (ttm)	192.39B
Net Income (ttm)	24.12B
Shares Out	17.60M
EPS (ttm)	1,370.68
PE Ratio	5.89
Forward PE	n/a
Dividend	110.00 (1.38%)
Ex-Dividend Date	Dec 27, 2024

Volume	17,563
Average Volume	81,964
Open	7,900.00
Previous Close	7,840.00
Day's Range	7,860.00 - 8,070.00
52-Week Range	4,850.00 - 11,410.00
Beta	0.81
RSI	43.04
Earnings Date	Aug 14, 2025

About Sage Therapeutics

MSC Co., Ltd., together with its subsidiaries, engages in the research and development, production, marketing, and sale of various food additives in South Korea. Its product portfolio includes carrageenan, a polysaccharide that is used in food systems, pharmaceuticals, cosmetics, and other applications; agar-agar, a non-digestible polysaccharide for making jellies, cookies, tissue culture, and bacteriological cultivation bases; natural food colors; concentrated juices produced from fruits and vegetables; and extracts from various cereals and he...

• Industry: Miscellaneous Food Preparations And Kindred Products
• Founded: 1974
• Employees: 440
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009780

Financial Performance

In 2024, MSC Co., Ltd.'s revenue was 189.76 billion, an increase of 0.37% compared to the previous year's 189.05 billion. Earnings were 21.76 billion, an increase of 17.85%.

Financial numbers in IDR